{"id":339187,"date":"2025-08-12T19:07:12","date_gmt":"2025-08-12T19:07:12","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/339187\/"},"modified":"2025-08-12T19:07:12","modified_gmt":"2025-08-12T19:07:12","slug":"new-evolution-engine-can-mutate-target-genes-100000-times-faster-than-normal","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/339187\/","title":{"rendered":"New \u201cEvolution Engine\u201d Can Mutate Target Genes 100,000 Times Faster Than Normal"},"content":{"rendered":"<p id=\"isPasted\">The evolution of proteins isn\u2019t just something that happens out in the wild. It can happen in the lab, too, and brings with it the possibility of developing new and improved proteins that can be used in all sorts of useful ways. Trouble is, that\u2019s also a massive slog \u2013 until now.<\/p>\n<p>The rest of this article is behind a paywall. Please sign in or subscribe to access the full content.<\/p>\n<p>A team from the Department of Chemistry and Skaggs Institute for Chemical Biology at the Scripps Research Institute have developed a so-called \u201cevolution engine\u201d, which can continuously introduce mutations into living bacterial cells at a rate 100,000 times higher than it would naturally acquire them.<\/p>\n<p>\u201cThis is like giving evolution a fast-forward button,\u201d said co-senior author Pete Schultz, the President and CEO of Scripps Research, in a <a href=\"https:\/\/www.scripps.edu\/news-and-events\/press-room\/2025\/20250807-schultz-evolution-engine.html\" target=\"_blank\" rel=\"noopener\">statement<\/a>. \u201cYou can now evolve proteins continuously and precisely inside cells without damaging the cell\u2019s genome or requiring labor-intensive steps.\u201d<\/p>\n<p>The \u201cengine\u201d is called T7-ORACLE and works by introducing an artificial DNA replication system into E. coli. Yep, you read that right; not all <a href=\"https:\/\/www.iflscience.com\/e-coli-the-archetypal-single-celled-organism-has-a-secret-multicellular-lifestyle-67289\" target=\"_blank\" rel=\"noopener noreferrer\">E. coli<\/a>\u00a0gives you an iffy belly \u2013 it\u2019s also widely used to produce proteins, as it grows easily and rapidly.<\/p>\n<p>This second, separate replication system doesn\u2019t target E. coli\u2019s main, chromosomal DNA, leaving the host cell unaffected. Instead, it targets small, circular pieces of DNA called <a href=\"https:\/\/www.iflscience.com\/a-new-mini-organ-has-been-discovered-in-mammalian-cells-70932\" target=\"_blank\" rel=\"noopener noreferrer\">plasmids<\/a>, which are often introduced into bacteria for the purpose of producing large amounts of proteins.<\/p>\n<p><img decoding=\"async\" class=\"inline-image fr-fic fr-dib\" data-asset-id=\"85719\" src=\"https:\/\/www.europesays.com\/uk\/wp-content\/uploads\/2025\/08\/20250807-schultz-evolution-engine-920x500.jpg\" alt=\"Schematic of the T7-ORACLE system. The genome is maintained by the non-mutagenic host replisome (gray), while an orthogonal T7 replisome (red) maintains only a dedicated plasmid (OR) at 100,000-fold elevated mutation rate.\" title=\"Schematic of the T7-ORACLE system. The genome is maintained by the non-mutagenic host replisome (gray), while an orthogonal T7 replisome (red) maintains only a dedicated plasmid (OR) at 100,000-fold elevated mutation rate.\" loading=\"lazy\"\/><\/p>\n<p>The T7-ORACLE system.<\/p>\n<p>Image credit: Scripps Research<\/p>\n<p>According to the researchers, it\u2019s a simple system to set up. \u201cThe main thing that sets this apart is how easy it is to implement,\u201d said co-senior author Christian Diercks, an assistant professor of chemistry at Scripps Research. \u201cThere\u2019s no specialized equipment or expertise required. If you already work with E. coli, you can probably use this system with minimal adjustments.\u201d<\/p>\n<p>The team tested the system out with a gene encoding a protein that gives bacteria <a href=\"https:\/\/www.iflscience.com\/antibiotic-resistance-how-were-trying-to-win-the-microscopic-arms-race-76106\" target=\"_blank\" rel=\"noopener noreferrer\">antibiotic resistance<\/a>, and gradually exposed E. coli cells to increasingly high doses of antibiotics. The results were impressively rapid; it took less than a week for a protein to evolve that could handle a dose up to 5,000 times higher than the first.<\/p>\n<p>\u201cThis system represents a major advance in continuous evolution,\u201d said Diercks. \u201cInstead of one round of evolution per week, you get a round each time the cell divides \u2013 so it really accelerates the process.\u201d<\/p>\n<p>It\u2019s hoped that the T7-ORACLE system could be at its most useful in medicine, helping to speed up the process of finding new and improved therapeutic proteins for all kinds of conditions, including cancers and <a href=\"https:\/\/www.iflscience.com\/alzheimers-linked-protein-levels-20-times-higher-in-newborn-babies-what-does-this-mean-79955\" target=\"_blank\" rel=\"noopener noreferrer\">neurodegenerative diseases<\/a>.<\/p>\n<p>\u201cWhat\u2019s exciting is that it\u2019s not limited to one disease or one kind of protein,\u201d Diercks explained. \u201cBecause the system is customizable, you can drop in any gene and evolve it toward whatever function you need.\u201d<\/p>\n<p>\u201c[W]e can now evolve virtually any protein, like cancer drug targets and therapeutic enzymes, in days instead of months.\u201d<\/p>\n<p>The study is published in <a href=\"https:\/\/doi.org\/10.1126\/science.adp9583\" target=\"_blank\" rel=\"noopener\">Science<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"The evolution of proteins isn\u2019t just something that happens out in the wild. It can happen in the&hellip;\n","protected":false},"author":2,"featured_media":339188,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3846],"tags":[267,70,16,15],"class_list":{"0":"post-339187","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-genetics","9":"tag-science","10":"tag-uk","11":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115017367203097682","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/339187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=339187"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/339187\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/339188"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=339187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=339187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=339187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}